Home > National Drug Code (NDC) > Carbidopa and levodopa

Carbidopa and levodopa - 0615-3537-39 - (Carbidopa and levodopa)

Alphabetical Index


Drug Information of Carbidopa and levodopa

Product NDC: 0615-3537
Proprietary Name: Carbidopa and levodopa
Non Proprietary Name: Carbidopa and levodopa
Active Ingredient(s): 10; 100    mg/1; mg/1 & nbsp;   Carbidopa and levodopa
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Carbidopa and levodopa

Product NDC: 0615-3537
Labeler Name: NCS HealthCare of KY, Inc dba Vangard Labs
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA074260
Marketing Category: ANDA
Start Marketing Date: 19930901

Package Information of Carbidopa and levodopa

Package NDC: 0615-3537-39
Package Description: 30 TABLET in 1 BLISTER PACK (0615-3537-39)

NDC Information of Carbidopa and levodopa

NDC Code 0615-3537-39
Proprietary Name Carbidopa and levodopa
Package Description 30 TABLET in 1 BLISTER PACK (0615-3537-39)
Product NDC 0615-3537
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Carbidopa and levodopa
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 19930901
Marketing Category Name ANDA
Labeler Name NCS HealthCare of KY, Inc dba Vangard Labs
Substance Name CARBIDOPA; LEVODOPA
Strength Number 10; 100
Strength Unit mg/1; mg/1
Pharmaceutical Classes Aromatic Amino Acid Decarboxylation Inhibitor [EPC],DOPA Decarboxylase Inhibitors [MoA]

Complete Information of Carbidopa and levodopa


General Information